Targeted, programmable, and precise tandem duplication in the mammalian genome
Genome Research · 2023
DOI: 10.1101/gr.277261.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, 2023. Verfasst von Yaoge Jiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, Chi…. Hauptthemen laut MEDLINE: Genome, DNA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, West China Hospital, Sichuan University.
Abstract (Originalsprache)
Tandem duplications are frequent structural variations of the genome and play important roles in genetic disease and cancer. However, interpreting the phenotypic consequences of tandem duplications remains challenging, in part owing to the lack of genetic tools to model such variations. Here, we developed a strategy, tandem duplication via prime editing (TD-PE), to create targeted, programmable, and precise tandem duplication in the mammalian genome. In this strategy, we design a pair of in trans prime editing guide RNAs (pegRNAs) for each targeted tandem duplication, which encode the same edits but prime the single-stranded DNA (ssDNA) extension in opposite directions. The reverse transcriptase (RT) template of each extension is designed homologous to the target region of the other single guide RNA (sgRNA) to promote the reannealing of the edited DNA strands and the duplication of the fragment in between. We showed that TD-PE produced robust and precise in situ tandem duplications of genomic fragments ranging from ∼50 bp to ∼10 kb, with a maximal efficiency up to 28.33%. By fine-tuning the pegRNAs, we achieved simultaneous targeted duplication and fragment insertion. Finally, we successfully produced multiple disease-relevant tandem duplications, showing the general utility of TD-PE in genetic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
- Center of Infectious Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610065, China.
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; shaohuayao@scu.edu.cn.
Förderung
- National Natural Science Foundation of China
- West China Hospital, Sichuan University
Zitieren
APA
Jiao, Y., Li, M., He, X., Wang, Y., Song, J., Hu, Y., Li, L., Zhou, L., Jiang, L., Qu, J., Xie, L., Chen, Q., & Yao, S. (2023). Targeted, programmable, and precise tandem duplication in the mammalian genome. Genome Research. https://doi.org/10.1101/gr.277261.122
Vancouver
Jiao Y, Li M, He X, Wang Y, Song J, Hu Y, et al. Targeted, programmable, and precise tandem duplication in the mammalian genome. Genome Research. 2023. doi:10.1101/gr.277261.122
BibTeX
@article{Jiao2023,
author = {Jiao, Yaoge and Li, Min and He, Xingyu and Wang, Yanhong and Song, Junwei and Hu, Yun and Li, Li and Zhou, Lifang and Jiang, Lurong and Qu, Junyan and Xie, Lifang and Chen, Qiang and Yao, Shaohua},
title = {Targeted, programmable, and precise tandem duplication in the mammalian genome},
journal = {Genome Research},
year = {2023},
doi = {10.1101/gr.277261.122}
}
EUVIMED